<DOC>
	<DOCNO>NCT00332462</DOCNO>
	<brief_summary>The aim exploratory study evaluate rejection rate patient treat cyclosporine ( CsA ) precede oral administration cyclosporine micro emulsion de novo liver recipient . The blood level CsA CsA micro emulsion monitor C-2h monitoring . In addition , study assess safety treatment regimen .</brief_summary>
	<brief_title>A Study Evaluate Efficiency Intravenously Administered Cyclosporine de Novo Liver Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Inclusion Criteria About undergo primary liver transplant ( include live donor , split liver ) . Expected capable study participation full 6 month posttransplantation . Allograft biopsies possible . Exclusion Criteria The surgery multiorgan transplant . The patient previously transplant organ . The graft derive nonheart beat donor . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Liver transplantation , Cyclosporine</keyword>
</DOC>